SEC62 and colorectal carcinoma: Second, we merely observed phospho‐JNK altered with the change of Sec62 and verified JNK agonist and inhibitor had effects on CRC metastasis, but specific mechanisms of how Sec62 activated the MAPK/JNK pathway was still not elucidated.